1553 Effects of proteinuria on muscle oxygenation and microvascular reactivity in patients with pre-dialysis CKD: a post-hoc analysis

Abstract Background and Aims Vascular dysfunction is a hallmark of CKD. Previous studies showed an impaired microvascular reactivity in the skeletal muscles, which deteriorates in advanced CKD stages. This analysis aims to examine the impact of proteinuria on skeletal muscle oxygenation and microvas...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nephrology, dialysis, transplantation dialysis, transplantation, 2024-05, Vol.39 (Supplement_1)
Hauptverfasser: Theodorakopoulou, Marieta P, Zafeiridis, Andreas, Dipla, Konstantina, Faitatzidou, Danai, Koutlas, Aggelos, Iatridi, Fotini, Karagiannidis, Artemios, Stamatiou, Anastasia, Doumas, Michael, Papagianni, Aikaterini, Sarafidis, Pantelis
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Background and Aims Vascular dysfunction is a hallmark of CKD. Previous studies showed an impaired microvascular reactivity in the skeletal muscles, which deteriorates in advanced CKD stages. This analysis aims to examine the impact of proteinuria on skeletal muscle oxygenation and microvascular reactivity at rest, during an occlusion-reperfusion maneuver, and during exercise in patients with pre-dialysis CKD. Method 66 patients with CKD stage 2-4 were included in this post-hoc analysis; 24-h urine samples were used for evaluation of proteinuria. Continuous measurement of muscle oxygenation [tissue saturation index (TSI%)] via near-infrared-spectroscopy at rest, during occlusion-reperfusion and during a 3-min handgrip exercise (at 35% of maximal-voluntary-contraction). Results The study groups were similar in terms of age (proteinuric vs nonproteinuric: 68.4 ± 10.6 vs 67.2 ± 10.8; p = 0.676), eGFR (41.3 ± 18.9 vs 46.3 ± 14.8; p = 0.248) and BMI (28.4 ± 4.9 vs 28.1 ± 4.8; p = 0.803). Resting muscle oxygenation did not differ between study groups (proteinuric vs nonproteinuric: 63.35 ± 4.09 vs 62.34 ± 3.21; p = 0.280). During occlusion, proteinuric CKD patients had marginally lower TSI occlusion magnitude (25.77 ± 7.87 vs 29.95 ± 10.34; p = 0.074) but no difference in occlusion slope (−0.09 ± .03 vs -.10 ± .04; p = 0.134). During reperfusion, the TSI reperfusion slopes were significantly lower in proteinuric CKD (slope to max 1.03 ± .45 vs 1.39 ± 0.69; p = 0.035 and 10-sec slope: 1.34 ± .63 vs 1.92 ± .75; p = 0.002); hyperemic response was numerically lower in proteinuric CKD (7.13 ± 4.27 vs 8.89 ± 4.68; p = 0.131). Finally, during exercise no differences were detected in the average muscle oxygenation between-group (10.76 ± 6.05 vs 10.65 ± 5.39; p = 0.943). Conclusion Although no differences in resting muscle oxygenation were detected, CKD patients with proteinuria showed more impaired skeletal muscle oxidative capacity (as suggested by lower TSI magnidute during occlusion), and miscrovascular reactivity during reperfusion.
ISSN:0931-0509
1460-2385
DOI:10.1093/ndt/gfae069.536